发明授权
- 专利标题： Functionally selective ALPHA2C adrenoreceptor agonists
- 专利标题（中）： 功能选择性ALPHA2C肾上腺素受体激动剂
-
申请号： US11705683申请日： 2007-02-13
-
公开(公告)号： US08003624B2公开(公告)日： 2011-08-23
- 发明人: Kevin D. McCormick , Christopher W. Boyce , Younong Yu
- 申请人： Kevin D. McCormick , Christopher W. Boyce , Younong Yu
- 申请人地址： US NJ Kenilworth US NJ Princeton
- 专利权人： Schering Corporation,Pharmacopeia, Inc.
- 当前专利权人： Schering Corporation,Pharmacopeia, Inc.
- 当前专利权人地址： US NJ Kenilworth US NJ Princeton
- 代理商 Gerard Devlin; H. Eric Fischer
- 主分类号： A01N57/00
- IPC分类号： A01N57/00 ; C07D215/38 ; C07D209/04 ; C07D223/16
摘要：
In its many embodiments, the present invention provides a novel class of indolines as inhibitors of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.
公开/授权文献
- US20080027100A1 Functionally selective alpha2C adrenoreceptor agonists 公开/授权日：2008-01-31